These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 28143871)
1. Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas. Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M Clin Cancer Res; 2017 Jul; 23(14):3884-3895. PubMed ID: 28143871 [No Abstract] [Full Text] [Related]
2. DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC). Sannigrahi MK; Sharma R; Singh V; Panda NK; Rattan V; Khullar M Mol Cell Biochem; 2018 Nov; 448(1-2):321-333. PubMed ID: 29455435 [TBL] [Abstract][Full Text] [Related]
3. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma. Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721 [TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750 [No Abstract] [Full Text] [Related]
5. Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways. Yao S; Xu J; Zhao K; Song P; Yan Q; Fan W; Li W; Lu C Cell Death Dis; 2018 Oct; 9(11):1055. PubMed ID: 30333561 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Gubanova E; Brown B; Ivanov SV; Helleday T; Mills GB; Yarbrough WG; Issaeva N Clin Cancer Res; 2012 Mar; 18(5):1257-67. PubMed ID: 22247495 [TBL] [Abstract][Full Text] [Related]
7. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions. Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417 [TBL] [Abstract][Full Text] [Related]
8. miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5. Sun X; Xiao D; Xu T; Yuan Y Future Oncol; 2016 Dec; 12(23):2701-2712. PubMed ID: 27513190 [TBL] [Abstract][Full Text] [Related]
9. Effects of HPV-16 infection on hypopharyngeal squamous cell carcinoma and FaDu cells. Lu W; Feng L; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W Oncol Rep; 2016 Jan; 35(1):99-106. PubMed ID: 26497405 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer. Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2. Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144 [TBL] [Abstract][Full Text] [Related]
12. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs. Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899 [TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction. Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832 [TBL] [Abstract][Full Text] [Related]
14. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration. Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506 [TBL] [Abstract][Full Text] [Related]
15. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2. Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050 [TBL] [Abstract][Full Text] [Related]
16. Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. Nulton TJ; Olex AL; Dozmorov M; Morgan IM; Windle B Oncotarget; 2017 Mar; 8(11):17684-17699. PubMed ID: 28187443 [TBL] [Abstract][Full Text] [Related]
17. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690 [TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Au Yeung CL; Tsang TY; Yau PL; Kwok TT Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962 [TBL] [Abstract][Full Text] [Related]
19. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA. Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779 [TBL] [Abstract][Full Text] [Related]
20. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs. Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]